Biotech and Pharmaceuticals
AstraZeneca takes stake in a start-up that helps doctors conduct clinical trials virtually
Medical syringes and small figurines of people are seen in front of the AstraZeneca logo displayed on a screen. On Saturday, March 26, 2021, in Dublin, Ireland. NurPhoto | NurPhoto | Getty Images LONDON — AstraZeneca said Wednesday it has invested in Huma, a U.K.-based medical technology start-up, as part of a broader commercial tie-up […]
Read More
Maverick Ventures’ Ambar Bhattacharyya on the future of health care
Ambar Bhattacharyya, managing director at Maverick Ventures Maverick Ventures Ambar Bhattacharyya is managing director at Maverick Ventures, a $400 million venture capital fund based in San Francisco which invests in health start-ups. His health-care portfolio firms include six IPOs and four unicorns (start-ups valued at $1 billion or more). Bhattacharyya — who currently sits on […]
Read More
Pfizer to supply 4 million Covid antiviral treatments to poorer nations through UNICEF
Paxlovid, a Pfizer’s coronavirus disease (COVID-19) pill, is seen manufactured in Ascoli, Italy, in this undated handout photo obtained by Reuters on November 16, 2021. Pfizer | Handout | via Reuters Pfizer will supply up to 4 million courses of its oral Covid-19 treatment to dozens of poorer nations under an agreement with the United […]
Read More
FDA advisory committee to discuss future of Covid boosters
A nurses fills up syringes for patients as they receive their coronavirus disease (COVID-19) booster vaccination during a Pfizer-BioNTech vaccination clinic in Southfield, Michigan, September 29, 2021. Emily Elconin | Reuters A Food and Drug Administration advisory committee will meet next month to discuss the future of Covid-19 booster shots in the U.S., and whether […]
Read More
Investors see growth opportunity in Femtech devoted to women’s health
To Dr. Connie Lehman, a breast cancer scan is like a fingerprint that provides clues for developing personalized medical care. “There is so much information in every digital image of a woman’s breast tissue, and the deep learning technology can extract that and predict the future and in ways we haven’t been able to […]
Read More
Here’s how Covid-19 transitions from a pandemic to endemic
It’s been two years since Covid-19 crept across the globe, battered the U.S. economy and wreaked havoc on health-care systems unprepared to defend themselves against the novel pathogen. Now, as the latest wave of infections driven by the fast-spreading omicron variant rapidly subsides, many are beginning to question: Is Covid-19 becoming endemic? “There’s a high […]
Read More
Pfizer CEO Albert Bourla received $24.3 million in total compensation for 2021
Pfizer CEO Albert Bourla addresses a press conference after a visit to oversee the production of the Pfizer-BioNtech COVID-19 vaccine at the factory of U.S. pharmaceutical company Pfizer in Puurs, Belgium April 23, 2021. John Thys | Pool | Reuters Pfizer CEO Albert Bourla received $24.3 million in total compensation for 2021, a 15% increase […]
Read More
Merck’s Keytruda reduced risk of disease recurrence or death in early lung cancer patients by 24%
Stefanie Joho, 27, stands for a portrait at the home of a friend in Penn Valley, PA on Tuesday, May 9, 2017. Joho, who was diagnosed with colon cancer at 22 years old, has been in remission since February 2016, thanks to an immunotherapy drug targeted at specific mutations that prevents repair of DNA-replication mistakes. […]
Read More
Biden names Dr. Ashish Jha new Covid response coordinator to succeed Jeff Zients
Dr. Ashish Jha is pictured in Providence, RI on Dec. 3, 2020. Jonathan Wiggs | Boston Globe | Getty Images President Joe Biden on Thursday named Dr. Ashish Jha as his new Covid-19 response coordinator to succeed Jeff Zients, who served in the role through the delta and omicron surges. Jha leads Brown University’s School […]
Read More
Moderna CEO Stephane Bancel has sold more than $400 million of company stock during the pandemic
Moderna CEO Stephane Bancel Steven Ferdman | Getty Images Moderna CEO Stephane Bancel has sold $408 million in company stock since the beginning of the coronavirus pandemic — averaging roughly $3.6 million a week — as the company’s stock soared on the development and rollout of its Covid vaccine, according to CNBC’s analysis of the […]
Read More